483
Mission Pharmacal CompanyFDA 483 - Mission Pharmacal Company - April 04, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Mission Pharmacal Company in Boerne, TX, a drug manufacturer, identified two significant issues. The facility's buildings used for drug manufacturing were not maintained in a good state of repair, exhibiting rust, peeling paint, and other deficiencies. Additionally, the firm's laboratory records were found to be deficient due to a lack of accountability for raw data documented on analytical sheets.
Open in Dashboard
ID · de4b9fd5-1991-46a8-aef1-60b534e3f5c9